191 related articles for article (PubMed ID: 4804082)
1. Carcinoembryonic antigen in patients with urologic cancers.
Guinan P; Ablin RJ; Barakat H; John T; Sadoughi N; Bush IM
Urol Res; 1973 Oct; 1(3):101-5. PubMed ID: 4804082
[No Abstract] [Full Text] [Related]
2. Carcinoembryonic antigen in patients with tumors of the urogenital tract.
Reynoso G; Chu TM; Guinan P; Murphy GP
Cancer; 1972 Jul; 30(1):1-4. PubMed ID: 5064805
[No Abstract] [Full Text] [Related]
3. Carcinoembryonic antigen and urothelial carcinoma.
Hall RR; Laurence DJ; Neville AM; Wallace DM
Br J Urol; 1973 Feb; 45(1):88-92. PubMed ID: 4690154
[No Abstract] [Full Text] [Related]
4. [Plasma and urinary CEA-assay in patients with urological tumours (author's transl)].
Hering H; Hering FJ; Weidner W
Urologe A; 1976 Nov; 15(6):300-3. PubMed ID: 1006894
[TBL] [Abstract][Full Text] [Related]
5. Immunologic features of genitourinary cancer.
Javadpour N
Urology; 1973 Aug; 2(2):103-8. PubMed ID: 4129366
[No Abstract] [Full Text] [Related]
6. Immunobiology of genitourinary tumors.
Lange PH; Hakala TR; Fraley EE
Urology; 1973 Nov; 2(5):485-92. PubMed ID: 4358375
[No Abstract] [Full Text] [Related]
7. Carcinoembryonic antigen (CEA) in plasma of patients with carcinoma of the bladder/urethra.
Orjasaeter H; Fosså SD; Schjølseth SA; Fjaestad K
Cancer; 1978 Jul; 42(1):287-95. PubMed ID: 667800
[No Abstract] [Full Text] [Related]
8. [Value of carcinoembryonic antigen (CEA) in the diagnosis of malignant tumors of the urogenital tract].
Rost A; Kneppenberg U; Rost P
Helv Chir Acta; 1976 Jul; 43(3):271-8. PubMed ID: 947865
[TBL] [Abstract][Full Text] [Related]
9. Novel immunotherapies in GU malignancies.
Drakaki A; McDermott DF
Curr Oncol Rep; 2013 Jun; 15(3):224-31. PubMed ID: 23519772
[TBL] [Abstract][Full Text] [Related]
10. [Carcinoembryonic antigen (CEA) in carcinoma of the upper urinary tract and bladder. Immunohistochemical study].
Lanzafame S; Puzzo L; Di Naso C; Di Marco G; Ranno S; Minardi G
Pathologica; 1986; 78(1056):451-8. PubMed ID: 3302887
[No Abstract] [Full Text] [Related]
11. Plasma levels of CEA as a prognostic marker in carcinoma of urinary bladder.
Alsabti EA; Saffo MH
Urol Int; 1979; 34(5):387-92. PubMed ID: 494440
[TBL] [Abstract][Full Text] [Related]
12. An Overview of Emerging Immunotargets of Genitourinary Tumors.
Montironi R; Santoni M; Cheng L; Lopez-Beltran A; Massari F; Matrana MR; Moch H; Scarpelli M
Curr Drug Targets; 2016; 17(7):750-6. PubMed ID: 26648079
[TBL] [Abstract][Full Text] [Related]
13. [Experience with combined cisplatin and radiation therapy for advanced urinary tract transitional cell carcinoma].
Yoshioka T; Utsunomiya M; Itoh H; Itatani H; Namiki M
Nihon Hinyokika Gakkai Zasshi; 1987 Mar; 78(3):518-24. PubMed ID: 3656856
[No Abstract] [Full Text] [Related]
14. [Evaluation of serum tissue polypeptide antigen (TPA) in patients with urogenital cancer].
Tozuka K; Yonese Y; Nakagami Y; Minowa T; Hiraoka Y; Yamada N; Hikima N; Ishii Y; Tannowa K; Fujioka Y
Gan To Kagaku Ryoho; 1984 May; 11(5):1078-83. PubMed ID: 6721513
[TBL] [Abstract][Full Text] [Related]
15. Immunohistochemical demonstration of tumor-associated antigens with the aid of monoclonal and polyclonal antisera in carcinoma of the bladder.
Steffens J; Friedmann W; Lobeck H
Urol Res; 1985; 13(2):55-9. PubMed ID: 2409654
[TBL] [Abstract][Full Text] [Related]
16. [Cooperation between specialists necessary in urologic oncology].
Bröte L
Lakartidningen; 1988 Oct; 85(40):3274-5. PubMed ID: 3199955
[No Abstract] [Full Text] [Related]
17. Lymphocyte-mediated cytotoxicity in patients with renal and transitional cell carcinoma receiving BCG.
Lange PH
Natl Cancer Inst Monogr; 1978 Dec; (49):343-5. PubMed ID: 748791
[TBL] [Abstract][Full Text] [Related]
18. Cytotoxicity of lymphocytes from patients with cancer of the urinary bladder: detection by a 3-H-proline microcytotoxicity test.
Bean MA; Pees H; FOGH JE; Grabstald H; Oettgen HF
Int J Cancer; 1974 Aug; 14(2):186-97. PubMed ID: 4477555
[No Abstract] [Full Text] [Related]
19. [Urological cancer: treatment strategies].
Srougi M; de Góes GM
AMB Rev Assoc Med Bras; 1983; 29(11-12):199-209. PubMed ID: 6369432
[No Abstract] [Full Text] [Related]
20. Antibody induction of lymphocyte-mediated cytotoxicity against human transitional-cell carcinomas of the urinary tract.
Hakala TR; Lange PH; Castro AE; Elliott AY; Fraley EE
N Engl J Med; 1974 Sep; 291(13):637-41. PubMed ID: 4859212
[No Abstract] [Full Text] [Related]
[Next] [New Search]